This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 22 PubMed articles · model: gemma4:31b
Summary
Crossopteryx febrifuga is a plant of the Rubiaceae family used in traditional African medicine to treat conditions such as trypanosomiasis, malaria, and pain [PMID:39401738, PMID:22468009].
Background
Crossopteryx febrifuga (Rubiaceae) is a savanna tree species found in Africa [PMID:39401738, PMID:28307253]. It is characterized by a high intrinsic resistance to fire due to its bark properties and thicker trunk compared to some other savanna species [PMID:28307253].
Traditional uses
In traditional African medicine, it is used to treat trypanosomiasis [PMID:39401738], malaria [PMID:22468009, PMID:36679099], painful inflammatory disorders [PMID:22468009], fever [PMID:40893781], epilepsy [PMID:40893781], depression [PMID:40893781], and various respiratory diseases [PMID:10632088].
Active compounds
Phytochemical profiling has identified organic acids, phenol derivatives [PMID:36679099], and various triterpenes from the stem bark, including a new ursane-type triterpene oxoglucopyranoside, 3β-d-glucopyranosyl-ursa-12,20(30)-diene-27,28-dioic acid, shanzhiside, shanzhiside methyl ester, β-sitosterol, hederagenin, and oleanolic acid [PMID:31525160, PMID:26352201]. Pectic-type polysaccharides (approximately 75%) have been isolated from the fruits [PMID:19150368].
Mechanism of action
Analgesic and anti-inflammatory properties of the methanolic stem bark extract may be mediated via non-selective inhibition of cyclo-oxygenase pathways [PMID:22468009]. Fruit extracts may exhibit anti-inflammatory activity by decreasing ROS production [PMID:36679099].
Clinical evidence
Evidence DTrypanosomiasis
Dichloromethane extracts showed antitrypanosomal activity against Trypanosoma brucei brucei with an IC50 of 9.3 ± 0.8 μg/mL [PMID:39401738].
Evidence DGastric Ulceration
Methanolic stem bark extract dose-dependently reduced ulcer index induced by ethanol (24-92%) and piroxicam (81.81-98.60%) in Wistar rats [PMID:22468009].
Evidence DMalaria
Stem bark ethanolic extracts showed dose-dependent chemo suppressive activities against parasitaemia in early and established infection stages in mice [PMID:15234749]; aqueous extracts showed significant antiplasmodial activity against Plasmodium falciparum chloroquine-resistant W2 strain (4 < IC50 < 10 μg/ml) [PMID:12738078].
Evidence DCough
Decoctions significantly decreased the number of citric acid-induced coughs in guinea-pigs at doses of 250, 500, and 1000 mg/kg (inhibition rates of 62.86%, 69.03%, and 77.44% respectively) [PMID:10632088].
Evidence DAmoebiasis/Spasms
Polyphenolic extracts inhibited Entamoeba histolytica growth (MAC < 10 μg/ml) and inhibited acetylcholine/KCl-induced contractions in guinea-pig ileum by more than 70% [PMID:10782488].
Safety & adverse effects
In mice, the mean survival period during established malaria infection tests was low, which was noted as a possible indication of toxicity resulting from sub-chronic administration of the extract [PMID:15234749]. Histopathological studies of rat stomach tissues were conducted to determine the safety profile of the stem bark extract on the gastrointestinal tract [PMID:22468009].
Evidence summary
The evidence consists primarily of in vitro studies and animal models (rats, mice, guinea-pigs), indicating potential antitrypanosomal, antimalarial, anti-inflammatory, and antitussive activities. There are no human clinical trials provided.
PubMed sources
1.PMID: 39401738 (2024) — Antitrypanosomal activity of Crossopteryx febrifuga and phytochemical profiling using LC-MS/MS analysis coupled to molecular network and SIRIUS. · Fitoterapia
2.PMID: 22468009 (2011) — Gastro-protective effect of Crossopteryx febrifuga in Wistar rats. · African journal of traditional, complementary, and alternative medicines : AJTCAM
3.PMID: 36679099 (2023) — Chemical Profile, Antioxidant and Anti-Inflammatory Potency of Extracts of Vitex madiensis Oliv. and Crossopteryx febrifuga (Afzel ex G. Don). · Plants (Basel, Switzerland)
4.PMID: 28307253 (1997) — Alternative fire resistance strategies in savanna trees. · Oecologia
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
EtOAc and n-BuOH extracts exhibited antibacterial activity against Pseudomonas aeruginosa (MIC 32 μg/mL) [PMID:31525160]. Silver nanoparticles synthesized using aqueous leaf extracts showed higher antibacterial activity against human skin pathogens than crude extracts [PMID:32793824].
— A new ursane-type triterpene oxoglucopyranoside from Crossopteryx febrifuga.
· Zeitschrift fur Naturforschung. C, Journal of biosciences
6.PMID: 21870639 (2011) — Sub-Saharan Rubiaceae: a review of their traditional uses, phytochemistry and biological activities. · Pakistan journal of biological sciences : PJBS
7.PMID: 15234749 (2004) — Antimalarial activities of Tithonia diversifolia (Asteraceae) and Crossopteryx febrifuga (Rubiaceae) on mice in vivo. · Journal of ethnopharmacology
8.PMID: 26352201 (2015) — Antimicrobial triterpenes from the stem bark of Crossopteryx febrifuga. · Zeitschrift fur Naturforschung. C, Journal of biosciences
9.PMID: 16213686 (2006) — Antioxidant and 15-lipoxygenase inhibitory activities of the Malian medicinal plants Diospyros abyssinica (Hiern) F. White (Ebenaceae), Lannea velutina A. Rich (Anacardiaceae) and Crossopteryx febrifuga (Afzel) Benth. (Rubiaceae). · Journal of ethnopharmacology
10.PMID: 32793824 (2020) — Green synthesis of antimicrobial silver nanoparticles using aqueous leaf extracts from three Congolese plant species (Brillantaisia patula, Crossopteryx febrifuga and Senna siamea). · Heliyon
11.PMID: 40893781 (2025) — Antidepressant effect of Crossopteryx febrifuga trunk bark aqueous extract on chronic stress-induced depression-related behaviors in male and female rats. · IBRO neuroscience reports
12.PMID: 10632088 (1999) — Effects of some Malian medicinal plants on the respiratory tract of guinea-pigs. · The Journal of pharmacy and pharmacology
13.PMID: 19150368 (2009) — Antitussive activity of polysaccharides isolated from the Malian medicinal plants. · International journal of biological macromolecules
14.PMID: 12738078 (2003) — Ethnobotanical survey and in vitro antiplasmodial activity of plants used in traditional medicine in Burkina Faso. · Journal of ethnopharmacology
15.PMID: 10782488 (2000) — Antiamoebic and spasmolytic activities of extracts from some antidiarrhoeal traditional preparations used in Kinshasa, Congo. · Phytomedicine : international journal of phytotherapy and phytopharmacology
16.PMID: 17825510 (2007) — Ethnobotanical survey and antibacterial activity of some plants used in Guinean traditional medicine. · Journal of ethnopharmacology